$2.96
-0.24-7.5%
Last update: Oct 2, 4:30 AM
$3.50
0.309.37%
Ernexa Therapeutics Inc
ERNANASDAQ
Ernexa Therapeutics (ERNA) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-3.30 | — | — | — |
| Actual | $-3.40 | $-6.95 | $-4.50 | $-3.75 |
| Surprise | -3.03% | — | — | — |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-3.84 | $-4.76 |
| Revenue | ||
| Consensus | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $-3.40 | $-3.30 | -3.03 % |
